Uso de páneles genómicos para la decisión de terapia sistémica por #cáncerdemama temprano. #BreastcancerMexico #Prosama https://t.co/uLGp9aLsnY
New2Trip: Role of Patient & Disease Factors in Adjuvant Systemic Therapy Decision-Making for Early-Stage, Operable Breast Cancer https://t.co/iemHYR5Iqw
SCI member Kimberly Allison and colleagues found that, depending on age and Oncotype DX recurrence score, there may be little to no benefit from chemotherapy for certain patients with early-stage, operable #breastcancer. https://t.co/q7AtcmeYlT
New2Trip: Role of Patient & Disease Factors in Adjuvant Systemic Therapy Decision-Making for Early-Stage, Operable Breast Cancer https://t.co/7TakjmgzMw
New2Trip: Role of Patient & Disease Factors in Adjuvant Systemic Therapy Decision-Making for Early-Stage, Operable Breast Cancer https://t.co/iemHYR5Iqw
New2Trip: Role of Patient & Disease Factors in Adjuvant Systemic Therapy Decision-Making for Early-Stage, Operable Breast Cancer https://t.co/iemHYRnji4
New2Trip: Role of Patient & Disease Factors in Adjuvant Systemic Therapy Decision-Making for Early-Stage, Operable Breast Cancer https://t.co/7TakjmgzMw
New2Trip: Role of Patient & Disease Factors in Adjuvant Systemic Therapy Decision-Making for Early-Stage, Operable Breast Cancer https://t.co/iemHYR5Iqw
Role of Patient and Disease Factors in Adjuvant Systemic Therapy Decision Making for Early-Stage, Operable Breast Cancer: Update of the ASCO Endorsement of the Cancer Care Ontario Guideline https://t.co/s7QuqRExaf
RT @DrAttai: Adjuvant therapy for early stage breast cancer, updated guideline endorsement from @ASCO https://t.co/aiiKMAoJGO #bcsm
RT @DrAttai: Adjuvant therapy for early stage breast cancer, updated guideline endorsement from @ASCO https://t.co/aiiKMAoJGO #bcsm
RT @DrAttai: Adjuvant therapy for early stage breast cancer, updated guideline endorsement from @ASCO https://t.co/aiiKMAoJGO #bcsm
RT @TheISBP: Role of Patient and Disease Factors in Adjuvant Systemic Therapy Decision Making for Early-Stage, Operable Breast Cancer: Upda…
Role of patient and disease factors in adjuvant systemic tehrapy decision-making for early-stage breast cancer - update of @ASCO endorsement of @CancerCare_ON guideline https://t.co/gwx7IuPX9w #bcsm https://t.co/K61FxXsZUN
RT @VCCLibrary: Role of Patient and Disease Factors in Adjuvant Systemic Therapy Decision Making for Early-Stage, Operable #BreastCancer: U…
Role of Patient and Disease Factors in Adjuvant Systemic Therapy Decision Making for Early-Stage, Operable #BreastCancer: Update of the ASCO Endorsement of the Cancer Care Ontario Guideline https://t.co/qDcSIgqMMA #cancer
RT @TheISBP: Role of Patient and Disease Factors in Adjuvant Systemic Therapy Decision Making for Early-Stage, Operable Breast Cancer: Upda…
Role of Patient and Disease Factors in Adjuvant Systemic Therapy Decision Making for Early-Stage, Operable Breast Cancer: Update of the ASCO Endorsement of the Cancer Care Ontario Guideline https://t.co/imLx5vAK5p